Ensign Peak Advisors
MLTX icon

Ensign Peak Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Ensign Peak Advisors’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.7K Hold
4,489
– – ﹤0.01% 1607
2025
Q4 		$59.2K Sell
4,489
-1,050
-19% -$12.4K ﹤0.01% 1656
2025
Q3 		$39.7K Sell
5,539
-3,600
-39% -$188K ﹤0.01% 1694
2025
Q2 		$431K Hold
9,139
– – ﹤0.01% 1594
2025
Q1 		$357K Hold
9,139
– – ﹤0.01% 1623
2024
Q4 		$495K Sell
9,139
-33,174
-78% -$1.69M ﹤0.01% 1597
2024
Q3 		$2.13M Sell
42,313
-10,874
-20% -$510K ﹤0.01% 916
2024
Q2 		$2.34M Hold
53,187
– – ﹤0.01% 848
2024
Q1 		$2.67M Sell
53,187
-461
-0.9% -$25K ﹤0.01% 818
2023
Q4 		$3.24M Buy
53,648
+44,048
+459% +$2.27M 0.01% 739
2023
Q3 		$547K Buy
+9,600
New +$530K ﹤0.01% 1563
2023
Q2 		– Sell
-11,575
Closed -$248K – 1768
2023
Q1 		$248K Buy
+11,575
New +$195K ﹤0.01% 1730

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return